Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival

• Published in: Journal of neuro-oncology 2023-04, Vol.162 (2), p.397-405
• Main Authors: Demetz, Matthias, Krigers, Aleksandrs, Moser, Patrizia, Kerschbaumer, Johannes, Thomé, Claudius, Freyschlag, Christian F.
• Format: Article
• Language: English
• Subjects: 2-Methylisoborneol; Adult; Brain Neoplasms - diagnostic imaging; Brain Neoplasms - genetics; Brain Neoplasms - pathology; Glioma; Glioma - diagnostic imaging; Glioma - genetics; Glioma - pathology; Headache; Humans; Magnetic Resonance Imaging; Medicine; Medicine & Public Health; Middle Aged; Neurology; Neuropathology; Oncology; Patients; Retrospective Studies; Survival; Tumors
• ISSN: 0167-594X; 1573-7373; 1573-7373
• DOI: 10.1007/s11060-023-04301-x

Purpose Data on differences in overall survival and molecular characteristics between incidental (iLGG) and symptomatic lower grade Glioma (sLGG) are limited. The aim of this study was to investigate differences between patients with iLGG and sLGG. Methods All adult patients with a histologically proven diffuse (WHO°II) or anaplastic (WHO°III) glioma who underwent their first surgery at the authors’ institution between 2010 and 2019 were retrospectively included. Tumor volume on pre- and postoperative MRI scans was determined. Clinical and routine neuropathological data were gained from patients’ charts. If IDH1, ATRX and EGFR were not routinely assessed, they were re-determined. Results Out of 161 patients included, 23 (14%) were diagnosed as incidental findings. Main reasons for obtaining MRI were: headache(n = 12), trauma(n = 2), MRI indicated by other departments(n = 7), staging examination for cancer(n = 1), volunteering for MRI sequence testing(n = 1). The asymptomatic patients were significantly younger with a median age of 38 years (IqR28-48) vs. 50 years (IqR38-61), p = 0.011. Incidental LGG showed significantly lower preoperative tumor volumes in T1 CE (p = 0.008), FLAIR (p = 0.038) and DWI (p = 0.028). Incidental LGG demonstrated significantly lower incidence of anaplasia (p = 0.004) and lower expression of MIB-1 (p = 0.008) compared to sLGG. IDH1-mutation was significantly more common in iLGG (p = 0.024). Incidental LGG showed a significantly longer OS (mean 212 vs. 70 months, p = 0.005) and PFS (mean 201 vs. 61 months, p = 0.001) compared to sLGG. Conclusion Our study is the first to depict a significant difference in molecular characteristics between iLGG and sLGG. The findings of this study confirmed and extended the results of previous studies showing a better outcome and more favorable radiological, volumetric and neuropathological features of iLGG.